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In the fall of 1994, ofﬁcials in Ohio discovered
that methyl parathion (MP) had been used for
domestic pest control, primarily in inner-city
homes (1–3). Further investigations uncovered
that an unlicensed operator had illegally
applied MP in hundreds of homes for cock-
roach control. This event resulted in costly
government-subsidized evacuations and home
decontaminations (4,5).
Since the episode in Ohio, similar incidents
have occurred in seven other Southeastern and
Midwestern States. To aid in prioritizing evac-
uation and decontamination efforts, the
Agency for Toxic Substances and Disease
Registry (ATSDR) asked our laboratory to pro-
vide biomonitoring data for residents affected
by these illegal applications. We developed a
rapid, high-throughput method for quantifying
a biomarker of MP exposure and applied this
method to assess MP exposure in residents of
contaminated homes.
MP is a highly toxic organophosphate
insecticide. Since its introduction in 1952, MP
has been used primarily for the control of boll
weevils on cotton (6). Its mode of action, com-
mon to all organophosphate insecticides, is the
competitive inhibition of acetylcholinesterase,
an enzyme responsible for the breakdown of
the neurotransmitter acetylcholine (7,8). MP is
classified as a restricted-use pesticide by the
U.S. Environmental Protection Agency (U.S.
EPA) (6). It is licensed only for use in outdoor
settings, and workers may not reenter fields
sprayed with MP for at least 4–5 days (9).
When applied properly in agricultural settings
where it is exposed to water and ultraviolet
(UV) light, MP has an environmental half-life
of days or weeks (6,10). When applied
indoors, the environmental half-life may
increase substantially.
MP has a biological half-life in animals of
7–17 hr (11,12). Upon exposure and subse-
quent bodily absorption, MP is rapidly
metabolized (Figure 1) to biologically active
methyl paraoxon. Methyl paraoxon can
chemically bind acetylcholinesterase, which
can ultimately result in a variety of clinical
outcomes including headaches, seizures, res-
piratory depression, paralysis, and death (5).
Further metabolism can result in the urinary
excretion of dimethylthiophosphate (DMTP),
dimethylphosphate (DMP), and p-nitrophenol
(PNP), either as the free phenol or as its
glucuronide or sulfate ester (13). The
dialkylphosphate metabolites of MP are
largely nonspeciﬁc because they are potential
metabolites of about 75% of the organophos-
phate pesticides registered with the U.S. EPA
(14). Although it is also a metabolite of
parathion, nitrobenzene, and a few similar
compounds, PNP is considered a more spe-
cific biomarker of exposure to MP than the
dialkylphosphate metabolites (3,15).
However urinary PNP can also result from
exposure to environmental PNP resulting
from the natural environmental degradation
of MP or parathion. After an acute exposure,
the majority of DMTP, DMP, and PNP is
excreted in urine within a few days (16–19).
However, chronic exposure to MP, as with
any nonpersistent organic toxicant, can result
in steady-state excretion of the metabolites.
Measurements of the change in acetyl-
cholinesterase activity from an individual’s
baseline (preexposure) acetylcholinesterase
activity is considered the “gold standard”
measurement for clinical assessment and
management of organophosphate intoxica-
tion (20). Unfortunately, in nonoccupational
exposures, baseline activity levels are difﬁcult
to obtain because usually an individual is seen
by a clinician after the exposure has occurred.
Furthermore, acetylcholinesterase depression
measurements typically lack the sensitivity to
detect low-level exposures.
Typically, PNP has been quantified in
urine as a more sensitive biomarker of expo-
sure to MP or parathion. These methods use
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Methyl Parathion
During the last several years, illegal commercial application of methyl parathion (MP) in
domestic settings in several U.S. Southeastern and Midwestern States has affected largely inner-
city residents. As part of a multiagency response involving the U.S. Environmental Protection
Agency (U.S. EPA), the Agency for Toxic Substances and Disease Registry (ATSDR), and state
and local health departments, our laboratory developed a rapid, high-throughput, selective
method for quantifying p-nitrophenol (PNP), a biomarker of MP exposure, using isotope dilu-
tion high-performance liquid chromatography–tandem mass spectrometry. We measured PNP
in approximately 16,000 samples collected from residents of seven different states. Using this
method, we were able to receive sample batches from each state; prepare, analyze, and quantify
the samples for PNP; verify the results; and report the data to the health departments and
ATSDR in about 48 hr. These data indicate that many residents had urinary PNP concentra-
tions well in excess of those of the general U.S. population. In fact, their urinary PNP concen-
trations were more consistent with those seen in occupational settings or in poisoning cases.
Although these data, when coupled with other MP metabolite data, suggest that many residents
with the highest concentrations of urinary PNP had significant exposure to MP, they do not
unequivocally rule out exposure to PNP resulting from environmental degradation of MP. Even
with their limitations, these data were used with the assumption that all PNP was derived from
MP exposure, which enabled the U.S. EPA and ATSDR to develop a comprehensive, biologi-
cally driven response that was protective of human health, especially susceptible populations,
and included clinical evaluations, outreach activities, community education, integrated pest
management, and decontamination of homes. Key words: mass spectrometery, methyl
parathion, p-nitrophenol, urine. Environ Health Perspect 110(suppl 6):1085–1091 (2002).
http://ehpnet1.niehs.nih.gov/docs/2002/suppl-6/1085-1091barr/abstract.html
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high-performance liquid chromatography
(HPLC) with UV or diode array detection
(21,22) or gas chromatography (GC) with
electron capture detection (23) and have lim-
its of detection ranging from 20 to 500 µg/L.
These methods lack the selectivity or the sen-
sitivity to measure trace amounts of PNP in
urine. More recently, our laboratory reported
a multianalyte method for the selective analy-
sis of 12 urinary pesticide metabolites, includ-
ing PNP, at the low microgram per liter level
(24). This method combined a solvent extrac-
tion of PNP from urine, a chemical derivatiza-
tion of PNP to its chloropropyl ether, and a
selective analysis using GC–tandem mass
spectrometry (GC–MS/MS). The major limi-
tation of this method was the lengthy chemi-
cal derivatization step (6 hr) required to
adequately analyze for the multiple analytes,
which severely limited the analytical through-
put of the method. With our multianalyte
method, 25 samples could be analyzed in
4 days. This was equivalent to 1 sample per
4 hr. To improve the analytical throughput
without sacriﬁcing method sensitivity or selec-
tivity, we opted to use HPLC–MS/MS, allow-
ing us to eliminate the need for chemical
derivatization.
We report our high-throughput and
selective method for the quantiﬁcation of uri-
nary PNP. Our new method is capable of
analyzing 160 samples in 2 days, or 1 sample
every 18 min, representing an almost 13-fold
increase in throughput. Using this method,
we were able to receive sample batches from
state and local health departments; prepare,
analyze, and quantify the samples for PNP;
verify the results; and report the data to
health departments and ATSDR in about
48 hr. We also report data obtained from
people exposed to MP or environmental PNP
as a result of its illegal residential application
in seven Southeastern and Midwestern States.
As a result of the epidemic nature of MP
exposure in the past several years, we have
accumulated what appears to be the largest
volume of biological monitoring data for a
single pesticide exposure cohort.
Materials and Methods
Materials
All chemicals unless otherwise indicated were
obtained in the purest form commercially
available from JT Baker Chemical Co.
(Phillipsburg, NJ, USA). PNP (gold label
99+% purity) was purchased from Aldrich
Chemical Co. (Milwaukee, WI, USA), and
ring-13C6-PNP (98% chemical purity,
99.99% isotopic purity) was purchased from
Cambridge Isotope Laboratories (Andover,
MA, USA). The enzyme β-glucuronidase/sul-
fatase from Helix pomatia was purchased from
Sigma Chemical Co. (St. Louis, MO, USA).
The gases for MS were obtained from Holox
(Norcross, GA, USA) or Air Products and
Chemicals Inc. (Atlanta, GA, USA) and had a
minimum purity of 99.999%. Our solvents,
including water, were analytic grade and were
obtained from Burdick and Jackson Co.
(Muskegon, MI, USA). All chemicals and
solvents were used without further puriﬁcation.
Reagents were prepared with bottled water
according to standard laboratory procedures.
Standard Preparation and
Characterization
Calibration standards. A PNP stock solution
was prepared by dissolving 18 mg PNP in
dimethylformamide (DMF). A 13C6-PNP
stock solution was prepared by dissolving 10
mg ring-13C6-PNP in DMF. The PNP and
13C6-PNP stock solutions were combined and
diluted with DMF to create eight standard sets
whose concentrations encompassed the linear
range of the method (10–800 µg/L in urine or
50–2500 ng on column). The stocks and
diluted standard sets were stored at –20°C.
Internal standard. A diluted 13C6-PNP
solution was prepared from the stock such that
a 25-µL aliquot gave an approximate 150-µg/L
concentration in 3 mL urine. The 13C6-PNP
concentration was adjusted to be close to the
expected or measured value to minimize error.
Diluted 13C6-PNP standards were divided into
aliquots sufﬁcient for two analytical runs and
were stored at –20°C until used.
Quality control materials. Quality control
(QC) materials were prepared in-house from
a base urine pool obtained from multiple
donors. The base urine was homogenized,
then split into three pools. One pool was not
enriched and thus reflected the endogenous,
or native, concentration of PNP in the urine.
The other two pools were enriched with dif-
ferent levels of PNP. Thus, QC pools with
native, low (approximately 75 µg/L), and
high (approximately 150 µg/L) concentra-
tions were obtained. All QC pools were
mixed thoroughly for 24 hr following enrich-
ment. The pools were ﬁltered through a ster-
ile membrane apparatus (0.2 µm pore size).
The filtered urine was dispensed in 20-mL
aliquots into sterile bottles. The bottles were
capped, labeled, and stored at –20°C until
used. All QC pools were characterized to
deﬁne the mean concentration and the 95th
and 99th conﬁdence intervals of PNP by the
analysis of at least 20 repeat measurements.
QC concentrations were evaluated using stan-
dard Westgard multirules (25).
Sample Preparation
Three-milliliter aliquots of urine were spiked
with 13C6-PNP. The urine samples were
diluted with an equal volume of 0.1 M
acetate buffer (pH 4.5) containing approxi-
mately 430 U/mL β-glucuronidase/sulfatase.
The sample tubes were capped and inverted
to mix. The urine/enzyme solutions were
allowed to incubate at 37°C overnight (about
17 hr) to liberate the PNP from the glu-
curonides or sulfate esters. The hydrolysates
were acidified with 200 µL 3 M HCl to a
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Figure 1. Schematic representation showing the potential metabolic byproducts of MP intoxication.
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pH of approximately 2. Ten milliliters
dichloromethane was added to each sample
and the tubes were inverted 10 times for
extraction. The samples were centrifuged at
2,000 rpm for 15 min to adequately separate
the organic and aqueous layers. The organic
layers were dried over anhydrous sodium sul-
fate and transferred to clean sample tubes. As
a keeper solvent, 100 µL DMF was added to
each extract and they were concentrated to
100 µL using a TurboVap concentrator
(Zymark Corporation, Hopkinton, MA) with
15 psi nitrogen head pressure at 37°C. The
concentrated extracts were transferred to
HPLC autosampler vials for analysis.
Instrumental Analysis
The HPLC-MS/MS analysis was performed
with an HP1090L HPLC (Hewlett-Packard
Co., Palo Alto, CA, USA) connected in tan-
dem to a TSQ-7000 triple quadrupole mass
spectrometer (Finnigan MAT Instruments,
San Jose, CA, USA) equipped with an atmos-
pheric pressure ionization (API) interface.
Separation was achieved on a 15 cm × 4.6
mm OD5 C18 column (Burdick and Jackson)
with 5-µm particles, which was preceded
inline by a 5-µm stainless steel frit to prolong
the column lifetime. The solvent system was
isocratic, consisting of 55:45 0.1% aqueous
ammonium bicarbonate (pH 7.8):0.1%
methanolic ammonium bicarbonate.
Negative atmospheric pressure chemical
ionization MS/MS was achieved by using
nitrogen as a sheath gas and argon as the col-
lision gas. No API auxiliary gas was used. The
pressure of nitrogen entering the API unit
was kept constant at 40 psi (276 kPa). The
argon gas pressure was 2 × 10–3 T (0.27 Pa).
The API vaporizer and capillary temperatures
were 400°C and 200°C, respectively. The dis-
charge of the corona needle was 5 µA. The
collision offset was at 24 V for optimal frag-
mentation. The electron multiplier voltage
ranged from 1,800 to 2,400 V.
During an analysis, eight product ions
were monitored in a multiple reaction moni-
toring (MRM) experiment at a scan time of
0.6 sec/ion. One quantiﬁcation and one con-
firmation ion were monitored for each the
native PNP and the 13C6-PNP. In addition,
one MS/MS transformation each was
monitored for the PNP dimer and the 13C6-
PNP dimer and two MS/MS transformations
for the mixed dimer. Table 1 lists the speciﬁc
transformations monitored. The appropriate
MRM specifications were recorded into an
acquisition program initiated immediately
upon injection of 10 µL of the sample extract
by the HPLC autoinjector. The total analysis
time per sample was about 3 min.
Typically, one analytical run consisted of
80 samples and was prepared for analysis by
one analyst. Of these samples, 10% were QC
materials, 10% were analytical standards, and
80% were unknown samples. One blank
urine sample was analyzed per run. One
instrument operated by one analyst was auto-
mated to analyze up to two analytical runs
(160 samples) per day. We routinely analyzed
160 samples per day with one instrument and
three to five analysts. Therefore, the total
sample throughput was 1 sample per 18 min,
or 30–55 samples per analyst day.
Data Processing/Analysis
Data were automatically processed by software
supplied with the mass spectrometer. Each ion
of interest was automatically selected, reten-
tion times were calculated, and the area was
integrated. All data were checked for interfer-
ences, peak selection, and baseline determina-
tion and were corrected if found in error. The
HPLC-MS/MS technique is highly selective
such that an analyte is identiﬁed as PNP only
if it meets the following criteria: a) elutes at a
speciﬁed retention time; b) coelutes with the
internal standard; c) possesses the same nomi-
nal mass as PNP; d) produces the same frag-
ment ions as PNP; and e) has the same relative
abundance (ratio of fragment ions) of frag-
ment ions as PNP. Because of this speciﬁcity,
interferences were rare. However, any interfer-
ences were easily recognizable because of a
dramatic change in the ratio of the quantiﬁca-
tion ions to the conﬁrmation ions of either the
native analyte or the internal standard. When
necessary, the data were reanalyzed to reﬂect
these corrections.
The data were downloaded into an ASCII
file and transferred from the UNIX-based
operating system on the TSQ-7000 to a PC
via an ethernet connection. The data were
imported into an R:BASE (Microrim,
Redmond, WA, USA) database specifically
designed for this analysis. The ratios of the
quantification and confirmation ions were
calculated. If the ratios were outside the 99%
conﬁdence limits, the analysis was repeated .
If the ratios remained outside the 99% conﬁ-
dence limits in the second analysis, the data
were considered unacceptable. All statistical
analyses including QC evaluations were per-
formed with SAS statistical software (SAS
Institute, Inc., Cary, NC, USA).
Quantiﬁcation
A calibration curve was constructed with the
log10 of eight different analyte concentrations
plotted against the log10 of the analyte
response factor. The lowest standard concen-
tration was near the method limit of detec-
tion (LOD) to ensure linearity at the low
concentration end. The response factors
(area/area internal standard) were calculated
according to established methods (24,26).
There were no apparent contributions of the
isotope to the native ions and native to the
isotope ion. A linear regression analysis of the
calibration plot provided a slope and inter-
cept from which concentrations of unknown
samples could be calculated. Over the dura-
tion of this study, approximately 300 repeat
determinations were performed for each
point on the calibration curve.
Method validation. The analytical LOD
of PNP was calculated as 3s0, where s0 is the
value of the standard deviation as the concen-
tration approaches zero. The s0 was deter-
mined as the y-intercept of a best-ﬁt line of a
plot of standard deviation of the standard
samples used in the calibration curve versus
the concentration (27).
Well-characterized pooled urine samples
were enriched with a known amount of the
native PNP standard and prepared accord-
ing to the procedure outlined above. After
the extraction, a known amount of 13C6-
PNP was added to each eluent, and the
samples were analyzed. A control sample,
which was a urine extract that did not con-
tain endogenous PNP, was enriched with
the same amount of native and labeled
PNP. The recovery of PNP from the extrac-
tion was calculated as a percentage of the
control PNP concentration, as the 13C6-
PNP corrected for any variation in instru-
mental response.
The method accuracy was evaluated by
enriching urine samples with a known
amount of native standard, preparing and
analyzing the samples, then comparing the
calculated concentration of the samples with
the expected concentration. A linear regres-
sion analysis was performed on a plot of the
calculated concentration versus the expected
concentration. A slope of 1.0 is indicative of
100% accuracy.
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Table 1. MS/MS speciﬁcations for MRM experiment.
Species Precursor ion Product ion Neutral loss Purpose of ion
PNP 138 108 NO Quantiﬁcation
PNP 138 92 NO2 Conﬁrmation
13C6-PNP 144 114 NO Quantiﬁcation
13C6-PNP 144 98 NO2 Conﬁrmation
2(PNP) 277 138 PNP QA
PNP–13C6-PNP 283 138 13C6-PNP QA
PNP–13C6-PNP 283 144 PNP QA
2(13C6-PNP) 289 144 13C6-PNP QA
QA, monitored for quality assurance.The method precision was determined by
calculating the coefﬁcient of variation (CV) of
repeat measurements of the QC materials. At
least 400 repeat measurements over a 2-year
period were used in the calculations. In addi-
tion, both interday and intraday variation
were determined.
Cross-Instrument Validation
To validate the use of additional TSQ-7000
mass spectrometers in our analyses, we ana-
lyzed at least 50 samples that had been previ-
ously run on a validated mass spectrometer.
These samples consisted of standards, QC
materials, and unknown samples. The data
from these analyses were plotted against the
previously obtained data. The slope of the
resultant linear regression analysis had to be
within ± 5% of 1.00 to cross-validate the new
mass spectrometer.
Biological Monitoring of Methyl
Parathion Exposure in Affected
Residents
Concentrations of PNP were determined in
the urine of people living in homes illegally
contaminated with MP. State health ofﬁcials
collected urine specimens in 30-mL sterile
Qorpak bottles (Qorpak, Pittsburgh, PA,
USA). Specimen bottles were closed with
polytetraﬂuoroethylene-lined screw caps, and
the bottles were labeled with an appropriate
specimen identiﬁcation number. The identiﬁ-
cation number consisted of a five-character
numeric code unique to the state and resi-
dence, followed by a three-character alphanu-
meric code that represented the particular
individual tested and time of collection (i.e.,
A.M. or P.M.). These samples were shipped on
dry ice overnight to our laboratory for testing.
Testing results were returned to the states
within 48 hr, on average. These results were
used to prioritize the relocation and deconta-
mination efforts and to follow exposures over
time to individuals in homes that were not
decontaminated. The speciﬁc biologically dri-
ven action criteria for relocation and deconta-
mination have been published elsewhere (28).
Briefly, three action levels were defined (no
further action needed, urine monitoring, relo-
cation), and the urinary PNP concentrations
required for these actions were broken into
three categories (<1 year of age or pregnant,
1–15 years of age, ≥16 years of age). Urinary
PNP concentrations resulting in continued
monitoring ranged from 25 to 600 µg/L ppb,
and those resulting in relocation ranged from
50 to 600 µg/L, both depending upon the
age/pregnancy category.
Results and Discussion
Solvent extraction with dichloromethane
proved to be simple and efﬁcient for extract-
ing PNP from the urine sample. The recov-
ery of PNP at 5 and 10 µg/L was 85 ± 8%
and 70 ± 3%, respectively. This simple
extraction step, when performed in batches
of 80 samples by one analyst, was completed
in approximately 3 hr. Although the cleanup
procedure was not highly selective, its simplic-
ity allowed a high sample throughput for the
method and minimized the errors normally
associated with nonautomated, complex
cleanup procedures.
Addition of an isotopically labeled
standard (13C6-PNP) prior to sample manip-
ulation, a technique known as isotope dilu-
tion (29), afforded us many advantages.
Chemically, 13C6-PNP behaves almost identi-
cally to PNP, but they are distinguishable
based upon the 6-atomic mass unit (amu) dif-
ference in their masses and respective frag-
ment ions (Figure 2). For this reason, the
ratio between their ions can internally correct
for recovery of PNP in each individual sam-
ple. This eliminates the need for recovery sur-
rogates. The automatic recovery correction
reduces the error associated with the measure-
ment and ultimately increases the method
sensitivity.
As shown in the spectra in Figure 2, the
major fragment ions produced during the
MS/MS transformation correspond to the
neutral loss of [NO] and [NO2]. These losses,
although common to most nitroaromatic
compounds, provided a great deal of selectiv-
ity to our analysis. Because we observed some
degree of dimer formation (i.e., 2PNP,
213C6-PNP, and PNP-13C6-PNP) during MS
analysis, we also monitored the MS/MS
transformations of the dimers to their respec-
tive monomers.
The method LOD was calculated to be
25 µg/L. Although this LOD was higher than
previously published methods (23,24), it was
suitable for categorizing samples into the vari-
ous priority levels required for public health
intervention. In subsequent studies we were
able to lower the method LOD to 81 ng/L as
calculated from calibration standards spiked
into urine. We obtained over a 300-fold
increase in sensitivity by modifying only a few
mass spectral parameters. More specifically,
by increasing the vaporizer and capillary tem-
peratures by up to 50°C, the dimer formation
became almost negligible. This increased the
amount of the monomers available for the
MS/MS transformations used in quantifica-
tion and decreased the number of transforma-
tions monitored during the chromatographic
retention window. These changes did not
alter the calibration of the analytical system.
A calibration plot is shown in Figure 3.
The PNP analysis was linear over two orders
of magnitude, with an r2 = 0.997. Similar cal-
ibration plots were obtained on multiple
instruments, providing us flexibility and
added resources when the sample load was
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Figure 2. Both the native PNP (A) and the 13C6-labeled PNP (B) fragment are almost identical but are distin-
guished based upon their 6-amu mass difference. The predominant neutral losses are NO and NO2.
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Figure 3. A calibration plot for PNP shows linearity
over almost three orders of magnitude. The r 2
value is 0.999.high. Cross-instrument validation studies
among three additional mass spectrometers
over the course of the study gave slopes rang-
ing from 0.998 to 1.0. This indicates that less
than 1% error was introduced by using mul-
tiple mass spectrometers.
The method’s accuracy was indistinguish-
able from 100%. A linear regression analysis
of a plot of the calculated concentrations of
spiked samples versus the expected concentra-
tions of the same samples yielded a slope of
1.0, which is indicative of a high degree of
accuracy. On average, the calculated value
was about 102% of the expected value.
A typical QC Shewart plot is shown in
Figure 4. This plot includes samples analyzed
on multiple instruments over a 2-year period
and reﬂects both intraday and interday varia-
tion. The statistical validity of an analytical
run was determined by evaluating the con-
centrations of the QC materials using the
standard Westgard rules (25).
The overall CVs and the intraday and
interday variations at two concentrations over
the linear range of the method are shown in
Table 2. As expected, the variation among
days was a greater contributor to the overall
CV than the variation within days.
The 1994 incident of illegal domestic use
of MP by commercial applicators in Lorain
County, Ohio, was our laboratory’s first
involvement in biomonitoring for MP expo-
sure in exposed populations (1,2), and it
affected approximately 250 homes. The
decontamination efforts cost the government
an estimated $20 million (4,5). From 1996 to
1997, similar incidences were reported in
seven additional states: Mississippi, Alabama,
Louisiana, Tennessee, Arkansas, Illinois, and
Texas. A multiagency response team compris-
ing the U.S. EPA, ATSDR, and state and
local health ofﬁcials was quickly constructed
to respond to this public health crisis. Our
laboratory assisted in prioritizing these decon-
tamination efforts by measuring urinary PNP
concentrations in about 16,000 samples from
affected residents. To date, an estimated $75
million has been spent on relocation of
affected residents and decontamination and
restoration of their homes (5).
A summary of the urinary PNP concen-
trations (micrograms per liter units) in about
16,000 samples is shown in Table 3. The
creatinine-adjusted data for the same indi-
viduals are also shown. The mean concentra-
tion differed significantly from the median
concentration for both the volume-based
and creatinine-adjusted data, indicating that
the data distribution was skewed. The mean
PNP concentration was roughly 15-fold
greater than the 95th percentile (upper
limit) of the reference range (5.2 µg/L) (30).
The median concentration was about 6
times the upper reference range; however,
the median was well below the maximum
concentration observed in the general U.S.
population. The creatinine-adjusted mean
was about an order of magnitude higher
than the upper reference range (3.8 µg/g cre-
atinine), whereas the creatinine-adjusted
median was about 4 times higher.
Concentrations were detectable in about
57% of the samples measured. This detec-
tion frequency is slightly higher than that
observed in the general U.S. population
(41%) (30); however, the lower limit of
reportable data for this study was 25 times
higher than the LOD of the reference range
study. If we were to impose the higher limit
of detection on the general population data,
<1% of the samples would have had
detectable urinary PNP concentrations. Less
than 1% of the samples contained interfering
substances that precluded the report of their
PNP concentrations.
PNP concentrations categorized by state
and compared with incidental, occupational,
and poisoning concentrations are shown in
Figure 5. The ranges shown by state include
multiple discrete samples from the same indi-
viduals, both adults and children. The upper
range of PNP concentrations in Illinois,
Louisiana, Mississippi, and Tennessee were
within the reported range of PNP levels
encountered in occupational exposures. In
addition, many of the samples tested in these
states had PNP levels within the ranges seen
in both nonfatal and fatal poisoning inci-
dences. No fatalities were reported in any of
the states tested.
Urinary PNP can result from exposure to
parathion, MP, environmental PNP (as the
degradation product of MP), and several
other sources. Therefore, we verified that
extremely elevated PNP concentrations (i.e.,
upper 1% of the distribution) in urine sam-
ples were, at least in part, a result of MP
exposure by measuring the additional MP
metabolites DMP and DMTP in the same
urine samples. These metabolites were quan-
tiﬁed using an isotope dilution GC–MS/MS
method (31). There was a strong positive cor-
relation between summed dialkylphosphate
molar concentrations and PNP molar con-
centrations (r = 0.78, p = 0.001). When eval-
uated by the individual dialkylphosphate,
both DMTP and DMP remained highly cor-
related with PNP concentrations (r = 0.90, 
p = 0.0001 and r = 0.39, p = 0.007, respec-
tively). As seen in Figure 6, two extremely
high values appear to skew the correlation of
DMTP and PNP. However, when these two
high values are removed, a good correlation
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Figure 4. QC plot showing data accumulated over a
2-year period. Mean concentration is 70 µg/L with
a CV of 12%.
Table 2. Method variation over 2 years.
Low pool High pool
CV (mean = 70 µg/L) (mean = 138 µg/L)
Total 12 14
Interday 9.2 9.4
Intraday 6.0 6.9
Table 3. Cumulative distribution of PNP in the urine
of people who lived in residences illegally sprayed
with MP.
Statistic µg/La µg/g creatinineb
n 15,904 15,762
Mean 75 60
Geometric mean 33 27
Median 31 26
5th percentile <25 5
95th percentile 230 190
Range <25 to 45,000 0–21,000
Frequency of 57% NA
detection
NA, not applicable. aNondetectable concentrations were
given a value equal to LOD/√– 2 for statistical evaluations.
bNondetectable concentrations were corrected for creati-
nine using LOD/√– 2.
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Figure 5. Distribution of urinary PNP in residents of
seven states compared with that of people
exposed occupationally (33–38) or through poison-
ings (33,36). For individual states, bars indicate the
5th to 95th percentile, the error bar shows the max-
imum, and the line shows the mean concentration.
For the occupationally and poisoning-exposed pop-
ulations, the bars indicate the entire range and the
line is the approximate mean.(Pearson coefﬁcient = 0.75, p = 0.0001) still
exists (Figure 6 inset). In about 65% of the
samples tested, DMP concentrations were
greater than DMTP concentrations in the
same sample. The DMP and DMTP concen-
trations ranged from less than the LOD to
145 µg/L and 460 µg/L, respectively. These
data are consistent with the reported abun-
dance of the dialkylphosphate metabolites of
MP after occupational exposures (32–34).
However, both DMP and DMTP concentra-
tions in the samples tested had geometric
means that were 11 and 5 times higher, respec-
tively, than the geometric means of these same
metabolites in the general population pub-
lished in the Centers for Disease Control and
Prevention National Report on Exposure to
Environmental Chemicals (35). Because the
dialkylphosphate metabolites are unlikely to be
effectively absorbed through the skin because
of their high polarity, these data suggest that
the urinary PNP measured in these samples
resulted, in part, from exposure to MP.
In many states, urine specimens were
collected in both morning and evening. This
sampling strategy was devised to evaluate
whether a spot sample collected during the
day would be representative of a 24-hr col-
lection. Multivariate and paired bivariate
analyses of the cumulative data and data cat-
egorized by state showed no significant dif-
ference between morning and evening PNP
concentrations whether or not the data were
creatinine adjusted. In fact, there was a
moderate yet significant positive Pearson
correlation (r = 0.39 volume-based, r = 0.44
creatinine adjusted, p = 0.0001) between
cumulative morning and evening PNP con-
centrations for both volume-based and crea-
tinine-adjusted analyses. In addition, some
individual states showed strong correlations
between morning and evening samples.
These data suggest that similar PNP concen-
trations would be obtained regardless of the
collection time.
In many states, residents whose urinary
PNP concentrations placed them in the mid-
dle action category were monitored on a quar-
terly basis to assess any changes in exposure
over time. A paired bivariate analysis showed a
signiﬁcant increase in urinary PNP concentra-
tions after the ﬁrst 3 months from a mean of
18 µg/g creatinine to a mean of 27 µg/g creati-
nine (p = 0.0021). For the next 6 months there
was no signiﬁcant change in urinary PNP con-
centrations (p > 0.05). However, after the next
3-month interval, the levels dropped signifi-
cantly to 20 µg/g creatinine (p = 0.0032),
nearer to the ﬁrst-quarter values.
Conclusions
We have developed a sensitive and selective
method for the quantification of PNP using
isotope dilution HPLC–MS/MS. We applied
this method to the analysis of about 16,000
samples collected from residents exposed to
MP and/or PNP from their homes, which
were contaminated by the illegal commercial
application of MP. These data indicate that
these residents had urinary PNP levels well in
excess of those of the general U.S. population.
These results enabled public health ofﬁcials to
implement a comprehensive, biologically dri-
ven response that included prioritization of
relocation and decontamination efforts so that
those who were most at risk were provided for
most urgently.
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